The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
guanfacine · Powder
1 marketed package NDCs · 1 active manufacturer
Most dispensed: HYDROCHLORIDE 2 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · HYDROCHLORIDE 4 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · HYDROCHLORIDE 3 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · HYDROCHLORIDE 1 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle
What changed in the last 90 days
Every detected change for guanfacine, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- GuanfacineAug 19, 2026Price downNADAC $0.18727 → $0.17834 per unit (-4.77%)
- GuanfacineAug 19, 2026Price upNADAC $0.16358 → $0.16603 per unit (+1.5%)
- GuanfacineAug 19, 2026Price downNADAC $0.16586 → $0.1573 per unit (-5.16%)
- GuanfacineAug 19, 2026Price downNADAC $0.13917 → $0.13245 per unit (-4.83%)
- GuanfacineAug 19, 2026Price upNADAC $0.26464 → $0.27213 per unit (+2.83%)
- GuanfacineAug 19, 2026Price upNADAC $0.14363 → $0.14423 per unit (+0.42%)
- GuanfacineAug 19, 2026Price downNADAC $0.18727 → $0.17834 per unit (-4.77%)
- GuanfacineAug 19, 2026Price upNADAC $0.16358 → $0.16603 per unit (+1.5%)
- GuanfacineAug 19, 2026Price downNADAC $0.16586 → $0.1573 per unit (-5.16%)
- GuanfacineAug 19, 2026Price downNADAC $0.13917 → $0.13245 per unit (-4.83%)
Same drug class
Other molecules FDA puts in Central alpha-2 Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- dexmedetomidine hcl· in shortage
- dexmedetomidine hydrochloride in 0.9% sodium chloride· in shortage
- dexmedetomidine· in shortage
- dexmedetomidine hydrochloride· in shortage
- clonidine hci· 1 maker
- clonidine hydrochloride oral· 1 maker
- dexmedetomidine hydrochloride in sodium chloride· 1 maker
- tizandine· 1 maker
- clonidine transdermal system· 2 makers
- guanfacine er· 2 makers
- tizanidine hcl· 2 makers
- gaunfacine· 3 makers
Common questions
- Is Guanfacine in shortage right now?
- No. FDA does not currently list Guanfacine in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Guanfacine?
- 31 companies have marketed Guanfacine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Guanfacine cost?
- The typical pharmacy pays about $0.1660 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.